紫杉醇對覆發性寡樹突膠質瘤有效！ Salvage Chemotherapy With Paclitaxel for Recurrent Oligodendrogliomas. J Clin Oncol 1997;15:3427-3432 郭集慶醫師彰基 ...µµ§ü¾J¹ïÂеo©Ê¹è¾ð¬ð½¦½è½F¦³®Ä¡ISalvageChemotherapyWithPaclitaxelforRecurrentOligodendrogliomas.JClinOncol1997;15:3427-3432³¢¶°¼yÂå®v¹ü°ò¤º¬ì³¡¸~½F¬ì¥D¥ô¦h¦~¨Ó¸~½F¬ìÂå¥Íª¾¹D¬Y¨Ç´c©Ê¯«¸g½¦½è½F¡]Gliomas¡^¹ï¤Æ¾ÇªvÀø¦³¤ÏÀ³¡A¦ý¬O¡A´N¬OµLªk¹w´ú¬O¨º¤@«¬ªº½¦½è½F¡C¦]¦¹¡A¤Ö¼Æ¸~½F¬ìÂå®v§¹¥þ´¬±ó¨Ï¥Î¤Æ¾ÇªvÀø·í¥L­±¹ïªº¬O´c©Ê¯«¸g½¦½è½F¯f¤H¡CÂå¾Ç¦b³o¤è­±ªº¶i®i¤]«Ü¦³­­¡A¤@ª½¨ì1988¦~¡A¥[®³¤jªºCairncross©MMacdonaldµoªí¥L­Ì¡u¦¨¥\ªº¡v¨Ï¥Î¤Æ¾ÇªvÀø©óÂеo©Ê´c©Ê¹è¾ð¬ð¯«¸g½¦½è½F±wªÌ¡A©Ò¨Ï¥Îªº¤Æ¾Ç°t¤è¦W¬°PCV¡e§tprocarbazine¡Blomustine¡]CCNU¡^©Mvincristine¡f¡C¤§«á©ó1992¦~¡AGlassJµ¥¥ç³ø§i²V¦X«¬½¦½è½F¦p§t¦³¹è¾ð¬ð¯«¸g½¦½è©Ê©M¬Pª¬¯«¸g½¦½è©Ê¨â³¡¥÷¤§½¦½è½F¡]©Ò¿×ªºoligoastrocytomas¡^¡A±`±`¹ïPCV¤Æ¾ÇªvÀø¦³¤ÏÀ³¡C¬°¦ó¹è¾ð¬ð¯«¸g½¦½è¨t¦Cªº´c©Ê½¦½è½F¨ã¦³¤Æ¾Ç±Ó·Pªº¯S©Ê©O¡H¥Ø«e¾ÇªÌ±À´ú¦¹Ãþ¸£½F¡]¤j³£ªø¦b¸£¤¤¡^ªº×Ã¥ý¨Ó¦Û¨ã¦³¦hºØ¼ç¯àªº¯«¸g½¦½è·F²Ó­M©Î¬O¨Ó¦Û¨ã¦³ÂùºØ¼ç¯àªº×Ã¥ý²Ó­M¡C¦¹Ãþ½¦½è½F¨ã¦³¯S§Oªº¬V¦âÅéÅܤÆ1p©M19q¥H¤Î§¹¾ãªºP53°ò¦]¡C¤]³\¹è¾ð¬ð¯«¸g½¦½è½F¹ïDNAalkylationªº¶Ë®`¨Ã¤£¯à¶i¦æ¦³®Äªº­×¸É¡A¤]¦³¾ÇªÌ»{¬°DNA¶Ë®`«á±Ò°Ê¤F²Ó­M­ä¤`apoptoticªº¾÷¨î¡C«áªÌªº°²»¡¨Ó¦Û©óÆ[¹î¨ì¹è¾ð¬ð¯«¸g½¦½è½F±`±`²Ö¿nP53³J¥Õ¦ý¬O¨Ã¨S¦³P53ªº¬ðÅܦs¦b¡CÁ{§É¤W¡A¹è¾ð¬ð¯«¸g½¦½è½F¦û©Ò¦³­ìµo©Ê¸£½Fªº¬ù3-7%¡C¹L¥h¨äªvÀø©M¤@¯ëªº½¦½è½F®t¤£¦h¡Aª½¨ì¤H­Ìµo²{¥¦¬O¨ã¦³¤Æ¾Ç±Ó·P©Ê¤§«á¡A¥Ø«eªvÀø¼Ò¦¡¦³¥²­n§â¤Æ¾ÇªvÀø¯Ç¤J¨ä¥D­n§ÜÀù­p¹º¤¤¡C¬ü°ê¸t¦a¤ú­ô¤§¥[§QçÄ¥§¨È¤j¾Ç¤§Chamberlain©MKormanik©ó1997¦~12¤ë¤§J.C.O.Àù¯gÂø»xµoªí¥L­Ì§¹¦¨ªº²Ä¤G¬ÛÁ{§É¬ã¨s¨Ï¥Îµµ§ü¾JªvÀøÂеo©Ê¤j¸£¥b²y¹è¾ð¬ð½¦½è¦¨¦~¯f¤H¡C¦@¦³¤Ü¦W¦¨¦~¤H¡A¤Q¥|¦ì¨k©Ê¡A¤¶©ó¤Q¤K¦Ü¤­¤Q¤G·³¡C©Ò¦³±wªÌ¹L¥h¬Ò±µ¨ü¹L¤â³N¡Binvolved-field©ñ®gªvÀø¡]¤¤¶¡­È¾¯¶q¬°55Gy¡^©MPCV¤Æ¾ÇªvÀø¡]¤¤¶¡­ÈÀøµ{¬°¤­­ÓÀøµ{¡^¡C©ó¦A¦¸Âеo®É¡A§@ªÌµ¹¤©µµ§ü¾J175²@§J¨C¦Ì¥­¤è¨C¹j¤T¦Ü¥|¶g­«ÂФ@¦¸¡C¨C¤K¶g§@¯«¸g¾Ç©M¯«¸g©ñ®g¶EÂ_¾Çªºµû¦ô¡Cµ²ªG¦Ê¤À¤§¤­¤Q¯f¤HÅã¥Ü¦³¯«¸g¶EÂ_¾Ç¤Wªº³¡¥÷½w¸Ñ©Îí©w¯e¯f¡C¨ä½w¸Ñ´Á¤¤¶¡¼Æ¬°¤Q­Ó¤ë¡C¦Ó¤Æ¾ÇªvÀø¬r©Ê³£¤£¤j¡C³o¼Ëªºµ²ªGÅý§Ú­Ì¦A¦¸¦Û°Ý¨ì©³°£¤F¹è¾ð¬ð¯«¸g½¦½è½F¥~¡AÁÙ¦³¨º¤@Ãþ«¬ªº¬Pª¬½¦½è½F¨ã¦³¤Æ¾Ç±Ó·P©Ê